FDA First Generic Drug Approvals

This resource is a public reference page mAIntained by the U.S. Food and Drug Administration that tracks first generic drug APProvals. It records instances where the agency cleared a generic veRSIon of a brand-name medicine for the first time, making it a useful starting point for anyone who needs to underStand which products have entered the generic market and when. Because the material comes from a government regulator, it is best treated as a primary source for regulatory status rather than a commercial product.

What it does

The page consolidates first generic approvals into a single browsable list. Each entry typically points to the drug in question and the approval ACTion, allowing readers to follow the Timeline of when a generic competitor became available for a given brand product. Rather than analyzing markets or predicting trends, it simply documents official approval activity as published by the agency.

Key capabilities

• ProvIDEs an official, publicly accessible record of first generic drug approvals.
• Supports lookup by drug or approval event, depending on how the agency organizes the listing.
• Links regulatory actions to the underlying product, helping users verify status.
• Functions as a citable reference for research, reporting and compliance work.
• Updates as new first generic approvals are issued, though timing may vary.

Who it is for

The page is relevant to pharmaceutical researchers, regulatory affairs specialists, healthcare analysts, journalists and students studying drug policy. Generic manufacturers may consult it to understand the competitive landscape, while payers and phArmacy Professionals can use it to confirm when a lower-cost alternative became officially available. It is not a consumer tool for comparing prices or checking Personal prescriptions, and it does not offer AI-driven analysis.

How to get started

1. Open the FDA page in a web browser; no account or installation is required.
2. Scan the approval list or use your browser's search function to locate a specific drug.
3. Follow the linked references to confirm details such as the approval date and product.
4. Cross-check with other FDA Databases if you need broader approval history.

Pricing and access caveat

Access is free and open, as is typical for U.S. government Information resources. There is no subscription, credit system or paid tier associated with the page. Visitors outside the United States should note that availability and accessibility of government sites may vary, and some content may be subject to regional or network restrictions. The page reflects regulatory records only; it does not provide medical advice, and details such as listing fORMat and update frequency may change without notice.